• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚(ADP-核糖)聚合酶抑制剂通过炎症和 Akt 信号通路减少大鼠心脏缺血/再灌注损伤。

Poly (ADP-ribose) polymerase inhibitor reduces heart ischaemia/reperfusion injury via inflammation and Akt signalling in rats.

机构信息

Department of Cardiology, Taian Central Hospital, Taian, Shandong 271000, China.

出版信息

Chin Med J (Engl). 2013;126(10):1913-7.

PMID:23673109
Abstract

BACKGROUND

Poly (ADP-ribose) polymerase (PARP) has been proposed to play an important role in the pathogenesis of heart ischaemia/reperfusion (I/R) injury. 3,4-dihydro-5-[4-(1-piperidinyl)butoxy]-1(2H)-isoquinolinone (DPQ), a potent PARP inhibitor, has cardiac protective effects. Because the underlying mechanisms are not understood, we investigated the effect of DPQ on heart I/R injury and its mechanisms.

METHODS

Studies were performed with I/R rats' hearts. DPQ was used to inhibit the activation of PARP. Cardiac function and cellular apoptosis were assessed. The activation of PARP, transcription factor nuclear factor-kappaB (NF-κB), intercellular adhesion molecule-1 (ICAM-1), cyclooxygenase-2 (COX-2) and matrix metalloproteinase-9 (MMP-9) were evaluated. We also evaluated expression of Akt and two of its downstream targets, glycogen synthase kinase-3β (GSK-3β) and forkhead transcription factor FOXO3a.

RESULTS

Administration of DPQ significantly decreased the activation of PARP and cellular apoptosis from (35 ± 5)% to (20 ± 4)% and simultaneously improved the cardiac function. DPQ reduced the expressions of NF-κB, ICAM-1, COX-2 and MMP-9 in rat heart and facilitated the activations of phosphor-Akt, phosphor-GSK-3β and phosphor-FOXO3a.

CONCLUSION

The protective effects of DPQ were associated with the suppression of inflammation and the activation of the Akt signalling pathways suggesting that the inhibition of poly (ADP-ribose) polymerase reduced heart I/R injury in rats.

摘要

背景

聚(ADP-核糖)聚合酶(PARP)被认为在心肌缺血/再灌注(I/R)损伤的发病机制中发挥重要作用。3,4-二氢-5-[4-(1-哌啶基)丁氧基]-1(2H)-异喹啉酮(DPQ),一种有效的 PARP 抑制剂,具有心脏保护作用。由于其潜在机制尚不清楚,我们研究了 DPQ 对心肌 I/R 损伤及其机制的影响。

方法

用 I/R 大鼠心脏进行研究。DPQ 用于抑制 PARP 的激活。评估心脏功能和细胞凋亡。评估 PARP、转录因子核因子-κB(NF-κB)、细胞间黏附分子-1(ICAM-1)、环氧化酶-2(COX-2)和基质金属蛋白酶-9(MMP-9)的激活。我们还评估了 Akt 及其两个下游靶点糖原合酶激酶-3β(GSK-3β)和叉头转录因子 FOXO3a 的表达。

结果

DPQ 的给药显著降低了 PARP 的激活和细胞凋亡,从(35±5)%降至(20±4)%,同时改善了心脏功能。DPQ 降低了大鼠心脏中 NF-κB、ICAM-1、COX-2 和 MMP-9 的表达,并促进了磷酸化-Akt、磷酸化-GSK-3β 和磷酸化-FOXO3a 的激活。

结论

DPQ 的保护作用与抑制炎症和激活 Akt 信号通路有关,表明抑制聚(ADP-核糖)聚合酶可减轻大鼠心肌 I/R 损伤。

相似文献

1
Poly (ADP-ribose) polymerase inhibitor reduces heart ischaemia/reperfusion injury via inflammation and Akt signalling in rats.聚(ADP-核糖)聚合酶抑制剂通过炎症和 Akt 信号通路减少大鼠心脏缺血/再灌注损伤。
Chin Med J (Engl). 2013;126(10):1913-7.
2
[Poly (ADP-ribose) polymerase contributes myocardial ischemia-reperfusion of rats by regulating Akt signaling pathway].
Zhonghua Xin Xue Guan Bing Za Zhi. 2013 Feb;41(2):156-60.
3
[Poly (ADP-ribose) polymerase inhibition attenuates ischemia/reperfusion induced myocardial injury in rat via reducing myocardial nuclear factor κB activity].[聚(ADP - 核糖)聚合酶抑制通过降低心肌核因子κB活性减轻大鼠缺血/再灌注诱导的心肌损伤]
Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Dec;40(12):997-1002.
4
Poly(ADP-ribose) polymerase inhibition protects epileptic hippocampal neurons from apoptosis via suppressing Akt-mediated apoptosis-inducing factor translocation in vitro.聚(ADP-核糖)聚合酶抑制通过抑制 Akt 介导的凋亡诱导因子易位体外保护癫痫海马神经元免于凋亡。
Neuroscience. 2013 Feb 12;231:353-62. doi: 10.1016/j.neuroscience.2012.11.009. Epub 2012 Nov 29.
5
Inhibition of the activity of poly (ADP-ribose) polymerase reduces heart ischaemia/reperfusion injury via suppressing JNK-mediated AIF translocation.抑制聚(ADP - 核糖)聚合酶的活性可通过抑制JNK介导的AIF易位来减轻心脏缺血/再灌注损伤。
J Cell Mol Med. 2008 Aug;12(4):1220-8. doi: 10.1111/j.1582-4934.2008.00183.x.
6
Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.PI3激酶/Akt激活在PARP抑制剂诱导的缺血再灌注期间心脏功能恢复中的关键作用。
Biochem Pharmacol. 2006 Feb 14;71(4):441-52. doi: 10.1016/j.bcp.2005.05.036. Epub 2005 Dec 6.
7
Involvement of independent mechanism upon poly(ADP-ribose) polymerase (PARP) activation in methylmercury cytotoxicity in rat cerebellar granule cell culture.大鼠小脑颗粒细胞培养中聚(ADP - 核糖)聚合酶(PARP)激活在甲基汞细胞毒性中的独立机制参与。
J Neurosci Res. 2008 Nov 15;86(15):3427-34. doi: 10.1002/jnr.21780.
8
The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts.Akt和丝裂原活化蛋白激酶系统在聚(ADP-核糖)聚合酶抑制对Langendorff灌注及异丙肾上腺素损伤大鼠心脏的保护作用中的角色。
J Pharmacol Exp Ther. 2005 Oct;315(1):273-82. doi: 10.1124/jpet.105.088336. Epub 2005 Jun 10.
9
Improved poststorage cardiac function by poly (ADP-ribose) polymerase inhibition: role of phosphatidylinositol 3-kinase Akt pathway.通过抑制聚(ADP-核糖)聚合酶改善储存后心脏功能:磷脂酰肌醇3-激酶Akt途径的作用
Transplantation. 2007 Aug 15;84(3):380-6. doi: 10.1097/01.tp.0000276924.08343.78.
10
Continuous inhibition of poly(ADP-ribose) polymerase does not reduce reperfusion injury in isolated rat heart.连续抑制多聚(ADP-核糖)聚合酶不会减少离体大鼠心脏的再灌注损伤。
J Cardiovasc Pharmacol. 2013 Jul;62(1):99-105. doi: 10.1097/FJC.0b013e318292c663.

引用本文的文献

1
Enhancing NAD Metabolome in Cardiovascular Diseases: Promises and Considerations.增强心血管疾病中的NAD代谢组:前景与考量
Front Cardiovasc Med. 2021 Aug 27;8:716989. doi: 10.3389/fcvm.2021.716989. eCollection 2021.
2
DNA Damage, an Innocent Bystander in Atrial Fibrillation and Other Cardiovascular Diseases?DNA损伤,是心房颤动及其他心血管疾病中的无辜旁观者?
Front Cardiovasc Med. 2020 Apr 28;7:67. doi: 10.3389/fcvm.2020.00067. eCollection 2020.
3
Role of Akt Activation in PARP Inhibitor Resistance in Cancer.Akt激活在癌症中对PARP抑制剂耐药性的作用。
Cancers (Basel). 2020 Feb 25;12(3):532. doi: 10.3390/cancers12030532.
4
Sex differences in Alzheimer's disease: Understanding the molecular impact.阿尔茨海默病中的性别差异:理解分子影响。
Brain Res. 2019 Sep 15;1719:194-207. doi: 10.1016/j.brainres.2019.05.031. Epub 2019 May 23.
5
Sex differences in the brain: Implications for behavioral and biomedical research.大脑中的性别差异:对行为和生物医学研究的启示。
Neurosci Biobehav Rev. 2018 Feb;85:126-145. doi: 10.1016/j.neubiorev.2017.07.005.
6
Olaparib protects cardiomyocytes against oxidative stress and improves graft contractility during the early phase after heart transplantation in rats.奥拉帕利可保护心肌细胞免受氧化应激,并改善大鼠心脏移植后早期移植物的收缩性。
Br J Pharmacol. 2018 Jan;175(2):246-261. doi: 10.1111/bph.13983. Epub 2017 Oct 2.
7
Sex differences in stroke therapies.中风治疗中的性别差异。
J Neurosci Res. 2017 Jan 2;95(1-2):681-691. doi: 10.1002/jnr.23855.
8
Human neutrophil peptides and complement factor Bb in pathogenesis of acquired thrombotic thrombocytopenic purpura.人中性粒细胞肽和补体因子Bb在获得性血栓性血小板减少性紫癜发病机制中的作用
Haematologica. 2016 Nov;101(11):1319-1326. doi: 10.3324/haematol.2016.149021. Epub 2016 Aug 4.
9
Neuroprotective activity of (1S,2E,4R,6R,-7E,11E)-2,7,11-cembratriene-4,6-diol (4R) in vitro and in vivo in rodent models of brain ischemia.(1S,2E,4R,6R,-7E,11E)-2,7,11-西柏三烯-4,6-二醇(4R)在脑缺血啮齿动物模型中的体内外神经保护活性。
Neuroscience. 2015 Apr 16;291:250-259. doi: 10.1016/j.neuroscience.2015.02.001. Epub 2015 Feb 10.
10
Targeting matrix metalloproteinase activity and expression for the treatment of viral myocarditis.针对基质金属蛋白酶活性和表达治疗病毒性心肌炎。
J Cardiovasc Transl Res. 2014 Mar;7(2):212-25. doi: 10.1007/s12265-013-9528-2. Epub 2014 Jan 1.